Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intraarticular and intravenous use. It enhances radiographic visualization during imaging procedures such as angiography, arthrography and computed tomography, allowing clinicians to assess vascular and joint structures in adult, pediatric and neonatal patients, thereby improving diagnostic confidence.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for diagnostic imaging programs globally.

Iomeron is an iodinated contrast agent used in radiographic procedures that require enhanced X‑ray attenuation. - Angiography: provides clear delineation of blood vessels for diagnostic and interventional procedures. - Arthrography: improves visualization of joint spaces to assess cartilage, ligaments and intra‑articular pathology. - Computed tomography (CT) imaging: enhances contrast between tissues, aiding detection of lesions and vascular structures.

Iomeron may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Warmth or flushing sensation at injection site. - Metallic taste in the mouth. - Nausea or vomiting. - Mild urticaria or itching. - Headache. - Transient hypotension.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Cardiovascular collapse or arrhythmia. - Pulmonary edema. - Seizures. - Death (rare).

Prior to using Iomeron, clinicians should observe several safety considerations to minimize risk. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Screen for iodine or contrast media allergy: obtain detailed allergy history. - Monitor thyroid status: avoid use in patients with uncontrolled hyperthyroidism. - Use caution in pregnancy: limited data, weigh diagnostic benefit against potential fetal exposure. - Adjust metformin therapy in patients with renal impairment: consider temporary discontinuation. - Store below 25°C: keep in original container, protect from light and moisture.

Iomeron can interact with certain medications and substances, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: may increase iodine load. - High‑dose iodine supplements or thyroid hormone therapy: can exacerbate thyroid dysfunction. - Metformin in patients with renal impairment: risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask early signs of hypersensitivity. - ACE inhibitors or ARBs: can potentiate hypotensive effects. - Diuretics: may affect renal clearance of contrast. - NSAIDs: increase risk of renal injury when combined with contrast. - Calcium channel blockers: monitor blood pressure changes.